A biotech giant is reportedly set to scale back a planned €1 billion campus in Waterford.
The Business Post is reporting that Amgen is understood to be assessing plans to reduce their investment locally.
The US drug company announced in December that it was moving to acquire Horizon.
Just a month before, Horizon had announced that they had secured planning permission for a state-of-the-art drug substance manufacturing facility and office campus on the outskirts of Waterford City.
The project was to cost up to a billion euro and would become the new global headquarters for Horizon.
However, with that company in the process of being acquired, that work was halted.
The paper says it has now emerged that Amgen wants to build a new biotech facility in Ireland but has no need for the full campus originally planned.
The report states that the Waterford site is still attractive for the company because of the planning permission, but they may opt for a location in Dublin instead.
Plans for the Waterford site, in the IDA Business Park, had been for a facility to manufacture rare-disease biologic drugs as well as other medicines.
For all your latest Waterford news and sport, click here.
